Clorox Company (The) (NYSE:CLX)‘s stock had its “hold” rating restated by research analysts at Jefferies Group LLC in a research report issued on Friday. They currently have a $132.00 price target on the stock, down from their prior price target of $137.00. Jefferies Group LLC’s target price indicates a potential upside of 2.21% from the company’s current price. Jefferies Group also issued estimates for Clorox Company (The)’s Q1 2018 earnings at $1.39 EPS, Q2 2018 earnings at $1.32 EPS, Q3 2018 earnings at $1.22 EPS, FY2018 earnings at $5.55 EPS and FY2020 earnings at $6.25 EPS.

A number of other research firms also recently issued reports on CLX. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Barclays PLC reiterated an “equal weight” rating and set a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. BidaskClub downgraded shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective on the stock in a research note on Tuesday, July 4th. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Friday, June 30th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Clorox Company (The) has a consensus rating of “Hold” and an average target price of $127.39.

Clorox Company (NYSE:CLX) opened at 129.14 on Friday. The stock’s 50 day moving average is $134.59 and its 200 day moving average is $134.61. The stock has a market capitalization of $16.67 billion, a price-to-earnings ratio of 24.21 and a beta of 0.39. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the firm earned $1.30 earnings per share. The company’s quarterly revenue was up 2.9% on a year-over-year basis. Equities analysts predict that Clorox Company will post $5.66 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/jefferies-group-llc-reiterates-hold-rating-for-clorox-company-the-clx/1617361.html.

In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. American Beacon Advisors Inc. acquired a new stake in Clorox Company (The) in the first quarter valued at approximately $104,000. Parkside Financial Bank & Trust boosted its stake in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after acquiring an additional 29 shares in the last quarter. Valley National Advisers Inc. boosted its stake in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after acquiring an additional 5 shares in the last quarter. Blue Chip Partners Inc. boosted its stake in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after acquiring an additional 6 shares in the last quarter. Finally, Sun Life Financial INC boosted its stake in Clorox Company (The) by 10,344.4% in the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after acquiring an additional 931 shares in the last quarter. Institutional investors own 71.33% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.